Clinical Trials
21
Active:0
Completed:9
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:5
Phase 2:1
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Phase 1
5 (45.5%)Phase 3
2 (18.2%)Early Phase 1
1 (9.1%)Not Applicable
1 (9.1%)Phase 2
1 (9.1%)Phase 4
1 (9.1%)Automated AI-based System for Early Diagnosis of Diabetic Retinopathy
Not yet recruiting
- Conditions
- Diabetic Retinopathy
- First Posted Date
- 2022-04-12
- Last Posted Date
- 2022-04-12
- Lead Sponsor
- The New York Eye & Ear Infirmary
- Target Recruit Count
- 1000
- Registration Number
- NCT05324189
- Locations
- 🇺🇸
New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
Telemedicine in Age-Related Macular Degeneration
- Conditions
- Age Related Macular Degeneration
- First Posted Date
- 2021-04-28
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- The New York Eye & Ear Infirmary
- Target Recruit Count
- 1000
- Registration Number
- NCT04863391
- Locations
- 🇺🇸
New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
Age-related Macular Degeneration (AMD) and Cardiovascular Disease
- Conditions
- Age-related Macular DegenerationCardiovascular DiseasesCoronary Artery Disease
- First Posted Date
- 2019-09-12
- Last Posted Date
- 2019-09-12
- Lead Sponsor
- The New York Eye & Ear Infirmary
- Target Recruit Count
- 200
- Registration Number
- NCT04087356
- Locations
- 🇺🇸
New York Eye and Ear Infirmary, New York, New York, United States
Post Intravitreal Injection Topical NSAID vs. Patching
Phase 4
- Conditions
- Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
- Interventions
- First Posted Date
- 2019-04-17
- Last Posted Date
- 2019-04-17
- Lead Sponsor
- The New York Eye & Ear Infirmary
- Target Recruit Count
- 60
- Registration Number
- NCT03918590
- Locations
- 🇺🇸
New York Eye and Ear Infirmary, New York, New York, United States
The Effectiveness of Ologen® Collagen Matrix in Preventing Intraocular Pressure (IOP) Spikes After Ahmed Glaucoma Valve Surgery (AGV-FP7)
Phase 2
Terminated
- Conditions
- Glaucoma
- First Posted Date
- 2016-12-13
- Last Posted Date
- 2021-03-17
- Lead Sponsor
- The New York Eye & Ear Infirmary
- Target Recruit Count
- 30
- Registration Number
- NCT02990143
- Locations
- 🇺🇸
New York Eye and Ear Infirmary, New York, New York, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
No news found